Filing Flows › Comparisons › MREO vs BIOE
Mereo BioPharma Group vs Bio Essence: MREO and BIOE compared
Mereo BioPharma Group is the larger company: $800K of revenue in its latest quarter (Q3 2026) against $795K for Bio Essence (Q2 2026). Bio Essence is more profitable, with an operating margin of 35.1% against -777.2%.
Where the money goes: MREO and BIOE
Mereo BioPharma Group (MREO) · Q3 2026
Mereo BioPharma Group, Q3 2026: revenue $800K, operating margin -777.2%, net loss $5.9M, operating cash flow −$4.1M. The chart follows the revenue to costs, profit and cash.
Bio Essence (BIOE) · Q2 2026
Bio Essence, Q2 2026: revenue $795K (+207% year over year), operating margin 35.1%, net earnings $270K, operating cash flow $60K. The chart follows the revenue to costs, profit and cash.
| Mereo BioPharma Group (MREO) | Bio Essence (BIOE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $800K | $795K |
| Revenue growth, Y/Y | — | +207% |
| Gross margin | — | 59.2% |
| Operating margin | -777.2% | 35.1% |
| Net earnings | −$5.9M | $270K |
| Net margin | -732.9% | 34.0% |
| Operating cash flow | −$4.1M | $60K |
Questions
Which is bigger, Mereo BioPharma Group or Bio Essence?
Mereo BioPharma Group is the larger company: $800K of revenue in its latest quarter (Q3 2026) against $795K for Bio Essence (Q2 2026).
Is Mereo BioPharma Group or Bio Essence growing faster?
Bio Essence is more profitable, with an operating margin of 35.1% against -777.2%.
More: Mereo BioPharma Group earnings · how Mereo BioPharma Group makes money · Bio Essence earnings · how Bio Essence makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.